Company / SG&A Expense
CorMedix Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$68.2M
FY2025
5-year range
$13.9M / $68.2M
FY2021-FY2025
Trend
+127.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 10 years, ranging from $7M in FY2016 to $68M in FY2025.
Based on SEC 10-K filings.
$68M in FY2025 with a 5-year CAGR of +47.2%.
Increased from $36M to $68M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +61.0%
- 5-Year CAGR
- +47.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +47.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 127.7% year-over-year.
- Lowest sg&a expense in the period was in FY2016.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $68.2M | +127.7% |
| FY2024 | $30.0M | -16.3% |
| FY2023 | $35.8M | +119.0% |
| FY2022 | $16.3M | +17.8% |
| FY2021 | $13.9M | +40.7% |
| FY2020 | $9.9M | +22.2% |
| FY2019 | $8.1M | -6.7% |
| FY2018 | $8.7M | -2.6% |
| FY2017 | $8.9M | +21.2% |
| FY2016 | $7.3M | -28.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026